Browse > Article

Combined Chemotherapy and Radiotherapy versus Radiotherapy alone in the Management of Localized Angiocentric Lymphoma of the Head and Neck  

Chang Sei Kyung (Department of Radiation Oncology, Yonsei University, College of Medicine)
Kim Gwi Eon (Department of Radiation Oncology, Yonsei University, College of Medicine)
Lee Sang-Wook (Department of Radiation Oncology, Ulsan University, College of Medicine)
Park Hee Chul (Department of Radiation Oncology, Hallym University, College of Medicine)
Pyo Hong Ryull (Department of Radiation Oncology, Yonsei University, College of Medicine)
Kim Joo Hang (Department of Internal Medicine, Yonsei University, College of Medicine)
Moon Sun Rock (Department of Radiation Oncology, Wonkwang University, College of Medicine)
Lee Hyeong Sik (Department of Radiation Oncology, Dong-A University, College of Medicine)
Choi Eun Chang (Department of Otolaryngology, Yonsei University, College of Medicine)
Kim Kwang Moon (Department of Otolaryngology, Yonsei University, College of Medicine)
Publication Information
Radiation Oncology Journal / v.20, no.1, 2002 , pp. 17-23 More about this Journal
Abstract
Purpose : To clarify the clinical benefit derived from the combined modality therapy (CMT) consisting of chemotherapy (CT) and involved field radiotherapy (RT) for stage I and II angiocentric lymphomas of the head and neck. Materials and Methods : Of 143 patients with angiocentric lymphoma of the head and neck treated at our hospital between 1976 and 1995, 104 patients (RT group) received involved field RT alone with a median dose of 50.4 Gy (range : 20~70 Gy), while 39 patients (CMT group) received a median 3 cycles (range : 1~6 cycles) of CT before involved field RT. The response rate, patterns of failure, complications, and survival data of the RT group were compared with those of the CMT group. Results : Despite a higher response rate, local failure was the most common pattern of failure in patients of both groups. The patterns of failure, including the systemic relapse rate were not influenced by the addition of combination CT. Although both modalities were well tolerated by the majority of patients, aberrant immunologic disorders or medical illnesses, such as a hemophagocytic syndrome, sepsis, intractable hemorrhage, or the evolution of second primary malignancies were more frequently observed in patients of the CMT group. The prognosis of patients in the RT group was relatively poor, with a 5-year overall actuarial survival rate of 38% and disease-free survival rate of 32%, respectively. However, their clinical outcome was not altered by the addition of systemic CT. Achieving complete remission was the most important prognostic factor by univariate and multivariate analyses, but treatment modality was not found to be a prognostic variable influencing survival. Conclusions : Involved field RT alone for angiocentric lymphoma of the head and neck was insufficient to achieve an improved survival rate, but the addition of CT to involved field RT failed to demonstrate any therapeutic advantage over involved field RT alone.
Keywords
Chemotherapy; Radiotherapy; Angiocentric lymphoma;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Fechner RE, Lampin DW. Midline malignant reticulosis. Arch Otolaryngol 1972;95:467-476   DOI   PUBMED
2 Smalley SR, Cupps RE, Anderson JA, et al. Polymorphic reticulosis limited to the upper aerodigestive tract - naturalhistory and radiotherapeutic considerations. lnt J Radiat Oncol Biol Phys 1988;15:599-605   DOI
3 Lipford EH, Margolick JB, Longo DL, et al. Angioimmunoproliferative lesion : a clicopathologic spectrum of postthymic T-cell proliferation. Blood 1988;72:1674-1681   PUBMED
4 Ho FCS, Choy D, Loke SL, et al. Polymorphic reticulosis and conventional lymphomas of the nose and upper aerodigestive tract : a clinicopathologic study of 70 cases, and immunophenotypic studies of 16 cases. Hum Pathol 1990;21:1041-1050   DOI   ScienceOn
5 Jaffe ES, Chan JKC, Su lJ, et al. Report of the workshop on nasal and related extranodal angiocentric T/natural killermiology. Am J Surg Pathol 1996;20:103-111   DOI   ScienceOn
6 Kem WF, Spier CM, Hanneman EH, Manneman EH, Miller TP, Matzner M, Grogan TM. Neural cell adhesion molecule-positive peripheral T-cell lymphoma : a rare variant with a propensity for unusual sites of involvement. Blood 1992;79:2432-2437
7 Ramsay AD, Rooney N. Lymphomas of the head and neck 1: nasofacial T-cell Iymphomas. Oral Oncol Eur J Cancer 1993;29B:99-102
8 Drenou B, Lamy T, Amiot L, et al. CD3-CD56+ nonHodgkin's lymphoma with an aggressive behavior related to multidrug resistance. Blood 1997;89:2966-2974   PUBMED
9 Chan JKC, Ng CS, Lau WH, et al. Most nasal/nasopharyngeal lymphomas are peripheral T-cell neoplasms. Am J Surg Pathol 1987;11:418-429   DOI   ScienceOn
10 Grange C, Cabane J, Dubois A. et al. Centrofacial malignant granuloma. Medicine 1992;71:179-196   DOI   PUBMED
11 Aviles A, Rodriguez L, Guzman R, et al. Angiocetric Toell lymphoma of the nose, paranasal sinus and hard palate. Hematol Oncol 1992;10:141-147   DOI   PUBMED
12 Kassel SH, Echevarria RA, Guzzo FP. Midline melignant reticulosis (so-called lethal midline granloma). Cancer 1968;23:920-935
13 Ferry JA, Sklar J, Zukerberg LR, et al. Nasal lymphomaa clinicopathologic study with immunophenotypic and genotypic analysis. Am J Surg Pathol 1991;15:268-279   DOI   PUBMED   ScienceOn
14 Halperin EC, Dosoretz DE, Goodman M. Radiotherapy of polymorphic reticulosis. Br J Radiol 1982;55:645-649   DOI   ScienceOn
15 Jaffe ES. Pathologic and clinical spectrum of post-thymic T-cell malignancies. Cancer lnvest 1984;2:413-426   DOI   PUBMED   ScienceOn
16 Liang R, Todd D, Chan TK, et al. Treatment outcome and pronostic factors for primary nasal lymphoma. J Clin Oncol 1995;13:666-670   DOI   PUBMED
17 Fellbaum C, Hansmann ML, Lennert K. Malignant lymphomas of the nasal casal cavity and paranasal sinuses. Vichows Arch A 1989;414:399-405   DOI
18 Itami J, Itami M, Mikata A, et al. Non-Hodgkin's lymphoma confined to the nasal cavity : its relationship to the polymorphic reticulosis and results of radistion therapy. lnt J Radiat Oncol Biol Phys 1991; 20;797-802
19 Wong KF, Chan JKC, Lo ESF, Wong CSC. A study of the possible etiologic association of Epstein-Barr virus with reactive hemophagocytic syndrome in Hong Kong Chinese. Hum Pathol 1996;27:1239-1242   DOI   ScienceOn
20 Kim GE, Cho JH, Yang WI, et al. Angiocentric lymphoma of the head and neck: patterns of systemic failure afterradiation treatment. J Clin Oncol 2000;18:54-63   DOI   PUBMED
21 Sorbrevilla-Calvo P, Meneses A, Alfaro P. Radiotherapy compared to chemotherapy as initial treatment of angiocentriccentrofacial lymphoma (polymorphic reticulosis).Acta Oncol 1993;32:69-72   DOI   ScienceOn
22 Medeiros LJ, Peiper SC, Elwood L, et al. Angiocentric immunoproliferative lesions : a molecular analysis of eightcases. Hum Pathol Pathol 1991;22:1150-1157   DOI   ScienceOn
23 Chen HHW, Fong L, Su IJ, et al. Experienoe of radiotherapy in lethal midline grauloma with special emphasis on centrofacisl T-cell lymphoma : a retrospective analysis covring a 34-year period. Radiother Oncol 1996;38:1-6   DOI   ScienceOn
24 Fauci AS, Johnson RE, Wolf SM. Radiation therapy of midline granuloma. Ann lnt Med 1976;84:140-147
25 Ko YH, Kim CW, Park CS, et al. REAL classification of malignant lymphomas in the Republic of Korea. Cancer 1998;83:806-812   DOI   ScienceOn
26 Yamaguchi M, Kita K, Miwa H, et al. Frepuent expression of P-glycoprotein/MDR1 by nasal T-cell lymphoma cells. Cancer 1995;76:2351-1256   DOI   ScienceOn
27 Macon WR, William ME, Greer JP, et al. Natural killerIike T cell lymphoma; aggressive lymphomas of T-large granular lymphocytes. Blood 1996;87:1474-1483
28 van Grop J, de Bruin PC, Sie-Go DMDS, et al. Nasal T-cell lymphoma: a clinicopathologcal and immunophenotypicanalysis of 13 cases. Histopathology 1995;27:139-148   DOI   ScienceOn
29 McDonald TJ, DeRemee RA, Harrison EG. The proteanclinical features of polymorphic reticulosis (lethal midline granuloma). Laryngoscopy 1976;86:936-945   DOI   ScienceOn